Search
for
Sort by
Research 661–690 of 1000+
- Hair removal using an Nd: YAG laser system.
- <i>WNT10A</i> , dermatology and dentistry
- Polycystic ovary syndrome: A review for dermatologists
- Endocrine evaluation of hirsutism
- Sensitive skin
- Genetic Fate Mapping Using Site-Specific Recombinases
- Gender-Affirming Hormone Therapy for Transgender Men
- Trichotillomania in Children
- PCOS in Adolescence and Type 2 Diabetes
- Necrosis of the donor site after hair restoration with follicular unit extraction (FUE): A case report
- Nonvascular Complications of Injectable Fillers—Prevention and Management
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Skin disease in pregnancy
- Physiologic changes and dermatoses of pregnancy
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Is skin microneedling a good alternative method of various skin defects removal
- Hair removal using a pulsed-intense light source.
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology
- Icariin promotes mouse hair follicle growth by increasing insulin-like growth factor 1 expression in dermal papillary cells
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- INTERFERONS IN DERMATOLOGY
- Injectable Ag nanoclusters-based hydrogel for wound healing via eliminating bacterial infection and promoting tissue regeneration
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- An Update on Drug-Induced Pigmentation
- Literature Review of Cosmetic Procedures in Men: Approaches and Techniques are Gender Specific
- Psychotrichology: psychosomatic aspects of hair diseases
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Scalp Flaps
- Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia